2-pyrazinoylguanidine has been researched along with aldosterone in 1 studies
| Studies (2-pyrazinoylguanidine) | Trials (2-pyrazinoylguanidine) | Recent Studies (post-2010) (2-pyrazinoylguanidine) | Studies (aldosterone) | Trials (aldosterone) | Recent Studies (post-2010) (aldosterone) |
|---|---|---|---|---|---|
| 18 | 5 | 0 | 25,333 | 1,517 | 4,169 |
| Protein | Taxonomy | 2-pyrazinoylguanidine (IC50) | aldosterone (IC50) |
|---|---|---|---|
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0048 | |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 0.043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer, KH; Brown, LE; Gelarden, RT; Vary, JE; Vesell, ES | 1 |
1 trial(s) available for 2-pyrazinoylguanidine and aldosterone
| Article | Year |
|---|---|
Novel multivalent effects of pyrazinoylguanidine in patients with azotemia.
Topics: Adult; Aldosterone; Blood Pressure; Clinical Trials as Topic; Creatinine; Electrolytes; Female; Glomerular Filtration Rate; Guanidines; Humans; Male; Middle Aged; Pyrazines; Renin-Angiotensin System; Sodium; Urea; Uremia | 1990 |